Financial comparisons Poolbeg Pharma PLC
Equities
POLB
GB00BKPG7Z60
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.350 GBX | -4.40% |
|
+1.16% | +8.75% |
| 02/05 | Poolbeg Pharma PLC, 2025 Earnings Call, Apr 28, 2026 | |
| 29/04 | EARNINGS AND TRADING: Tullow Oil swings to annual loss as sales drop | AN |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| - | - | - | -48.83% | - | 1.3x | ||
| 649.89Cr | 42.13% | 52.64% | 28.56% | 20.88% | -0.99x | ||
| 422.56Cr | 30.41% | 24.81% | 20.15% | 17.36% | -3.18x | ||
| 336.96Cr | -39.59% | -48.95% | -5.88% | -5.1% | 6.99x | ||
| 61Cr | -210.54% | -205.59% | -249.28% | - | 0.72x | ||
| 311.53Cr | 22.53% | 31.44% | 11.9% | 8.13% | -1.19x | ||
| 369.4Cr | 25.89% | 28.63% | 17.53% | 9.99% | -1.51x | ||
| 44Cr | -36.42% | -29.57% | -7.45% | -4.07% | 6.67x | ||
| 29Cr | -18.56% | -24.05% | -9.34% | -9.05% | 6.63x | ||
| 96Cr | -30.08% | -31.31% | -42.49% | - | 2.15x | ||
| 232.01Cr | 33.73% | 37.59% | 35.53% | 27.02% | -1.18x | ||
| 83Cr | -0.2% | 11.86% | -0.5% | - | -6.61x | ||
| 46Cr | 21.89% | 3.81% | 25.37% | 11.13% | 2.25x | ||
| 8.8Cr | -891.6% | -695.44% | - | -55.55% | 0.05x | ||
| 115.83Cr | 23.46% | 22.49% | 20.46% | 11.16% | 0.73x | ||
| 11Cr | -310.18% | -226% | - | - | - | ||
| 50Cr | 32.27% | 31.52% | 16.97% | 14.74% | -3.83x | ||
| Average | 179.19Cr | -81.55% | -63.51% | -12.49% | 3.89% | 0.56x | |
| Weighted average by Cap. | 282.66Cr | -44.55% | -34.16% | -9.57% | 8.5% | 0.24x |
- Stock Market
- Equities
- POLB Stock
- Sector Poolbeg Pharma PLC
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















